PROFHILO H+L has established itself as one of the more clinically distinctive injectables available to aesthetic practitioners. Its dual molecular weight hyaluronic acid formula sets it apart from conventional HA fillers — addressing skin laxity, hydration, and tissue remodeling rather than simply adding volume. This article covers the formulation, indications, injection technique, and safety considerations practitioners need to know before incorporating PROFHILO H+L into their practice.

This information is intended for trained medical professionals. Not a substitute for formal training or manufacturer information.

Formulation: NAHYCO Hybrid Technology

PROFHILO H+L is manufactured by IBSA using patented NAHYCO Hybrid Technology — a thermal process that combines high molecular weight (H-HA) and low molecular weight (L-HA) hyaluronic acid into a stable hybrid complex without the use of chemical cross-linking agents. This is a key distinction from conventional cross-linked HA fillers.

Each component plays a distinct role:

• High molecular weight HA provides structural support, tissue scaffolding, and sustained skin hydration.
• Low molecular weight HA penetrates more deeply, stimulating fibroblast activity and promoting the production of collagen and elastin.

The absence of chemical cross-linkers improves biocompatibility and reduces the risk of inflammatory reactions. The hybrid complex integrates into the skin’s extracellular matrix in a way that closely mimics its natural HA composition, resulting in a more homogeneous distribution and a natural tissue response.

Each syringe contains 32mg of stabilized HA in 2mL — a relatively high concentration delivered in a low-viscosity formulation designed for superficial dermal injection rather than deep volumization.

Indications

PROFHILO H+L is indicated for skin remodeling and biostimulation rather than structural augmentation. It is not a volumizing filler. Primary indications include:

• Skin laxity: Loss of elasticity in the face, neck, décolletage, and hands responding to collagen and elastin stimulation.
• Fine lines and surface texture: Improvement of superficial lines and overall skin quality through tissue remodeling.
• Skin hydration: Deep, sustained hydration from the H-HA component, improving skin plumpness and radiance.
• Preventive treatment: Suitable for younger patients seeking to maintain skin quality before significant aging changes develop.

PROFHILO H+L is suitable for a range of skin types and ages. It is commonly used on the face, neck, décolletage, and hands. It is not indicated for structural volumization or deep fold correction — for those indications, conventional HA fillers or biostimulators remain more appropriate.

It can be used as a standalone treatment or combined with botulinum toxin, volumizing fillers, or energy-based devices as part of a layered rejuvenation protocol. When combining treatments, sequencing and appropriate timing between sessions should be observed.

Injection Technique

The standard injection protocol for PROFHILO H+L involves two treatment sessions spaced four weeks apart, with maintenance treatments recommended every six months.

The most widely adopted delivery method is the BAP (Bio Aesthetic Points) technique, which involves injecting the product at five specific anatomical points on each side of the face. These points are selected to optimize product distribution while avoiding high-risk vascular and nerve structures. Each injection delivers a bolus of product that spreads through the tissue planes, negating the need for extensive fanning or threading.

Alternative techniques include:

• Linear threading: Useful for targeted zones requiring more precise linear coverage.
• Fanning: Applicable for broader surface areas, particularly on the neck or décolletage.
• Layering: Used when addressing multiple depths of concern in a single session.

A fine needle (typically 25–27G) is recommended. Due to the product’s relatively low viscosity compared to volumizing fillers, injection pressure is moderate. Gentle massage post-injection helps ensure even distribution and reduces the likelihood of transient surface papules.

Safety Precautions

PROFHILO H+L has a well-established safety profile in clinical use. Its cross-linker-free formulation reduces the risk of chronic inflammatory reactions associated with some conventional HA fillers. That said, standard injectable safety protocols apply.

Key precautions include:

• Patient assessment: A thorough medical history should be taken prior to treatment, including screening for HA hypersensitivity, autoimmune conditions, active skin infections, and pregnancy or breastfeeding.
• Contraindications: Known allergy to hyaluronic acid, active infection or inflammation at the injection site, pregnancy, and breastfeeding.
• Aseptic technique: Standard sterile protocol must be maintained throughout — including site disinfection, sterile gloves, and single-use needles.
• Anatomical knowledge: Practitioners must be familiar with facial vascular anatomy. Although PROFHILO H+L is injected superficially, vascular structures must be identified and avoided at all injection points.
• Storage: Store below 25°C, away from direct sunlight. Do not freeze. Do not use past expiration date.

Common side effects are typically mild, temporary, and injection-site related: redness, swelling, bruising, tenderness, and transient papules at injection points. These generally resolve within a few days.

Rare but serious adverse events include vascular occlusion, severe allergic reaction, infection, and nodule or granuloma formation. Practitioners should be trained in complication recognition and management, and hyaluronidase should be accessible given the HA composition of the product.

Clinical Evidence

PROFHILO H+L’s efficacy is supported by clinical data across multiple published studies. Research has consistently demonstrated improvements in skin elasticity, hydration, and overall skin quality following a standard two-session protocol. A study published in the Journal of Cosmetic Dermatology reported significant improvements in skin elasticity and hydration after two treatments, with 86% of participants reporting meaningful improvement in skin quality. Patient satisfaction and tolerability rates have been high across the published literature.

The product holds CE marking and has been available in clinical practice for over a decade, with a substantial body of real-world safety data supporting its use across a range of patient profiles and skin types.

Conclusion

PROFHILO H+L occupies a distinct position in the injectable market — it is neither a volumizer nor a conventional skin booster, but a bioremodeling agent that improves skin quality at a structural level. Its NAHYCO hybrid formulation, cross-linker-free composition, and well-established BAP injection protocol make it a technically accessible and clinically differentiated option for practitioners building comprehensive rejuvenation protocols. Licensed medical professionals can purchase PROFHILO H+L at Health Supplies Plus.

Doris

About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.

Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.